30.01.2015 • News

BASF Quits R&D Pact With Novozymes and Cargill

BASF has said it will exit its current R&D collaboration with Novozymes and Cargill to develop a bio-based process for producing 3-hydroxypropionic (3-HP) and acrylic acid from renewable raw materials.

The German chemical giant did not give a reason for leaving the partnership, but may be planning to continue working on the bio-acrylic acid separately. When joining the research it said it hoped to fast-forward its entry into the market for bio-based superabsorbent polymers used to make baby diapers, adhesive raw materials and coatings.

In September 2014, the group said it was "working full force" to set up a small integrated pilot plant by the end of the year.

The two US companies, which began working together in 2008 before being joined by BASF in 2008, are now looking for a new commercialization partner.

"This is pioneering biochemical research, and the technology development and achievements so far have been extraordinary," said Kristian Bjørneboe, Vice President for Business Creation and Acquisition at Novozymes.

The R&D cooperation has achieved its technical and business targets, the companies said. After demonstrating the production of 3-HP at pilot scale in 2013, the partners said a year later they had successfully converted the product to glacial acrylic acid and superabsorbent polymers and had selected this process for further scale-up.

In the petrochemical route, acrylic acid is produced by oxidation of propylene derived from the refining of crude oil.

Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.